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Increased reactive oxygen species (ROS) production is crucial to the remodelling that occurs
in skeletal muscle in response to both exercise training and prolonged periods of disuse. This
review discusses the redox-sensitive signalling pathways that are responsible for this ROS-
induced skeletal muscle adaptation. We begin with a discussion of the sites of ROS production
inskeletalmuscleﬁbres.Thisisfollowedbyanoverviewoftheputativeredox-sensitivesignalling
pathwaysthatpromoteskeletalmuscleadaptation.Speciﬁcally,thisdiscussionhighlightsredox-
sensitive kinases, phosphatases and the transcription factor nuclear factor-κB. We also discuss
theevidencethatconnectsredoxsignallingtoskeletalmuscleadaptationinresponsetoincreased
muscular activity (i.e. exercise training) and during prolonged periods of muscular inactivity
(i.e. immobilization). In an effort to stimulate further research, we conclude with a discussion
of unanswered questions about redox signalling in skeletal muscle.
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The observation that muscular exercise increases the
production of free radicals and other reactive oxygen
species (ROS) in skeletal muscles was ﬁrst reported
by Davies et al. (1982). Paradoxically, it was later
discovered that ROS generation also increases in skeletal
muscle ﬁbres following prolonged periods of disuse (e.g.
immobilization; Kondo et al. 1991). Since these early
observations, many studies have conﬁrmed that both
muscular exercise and long periods of muscle disuse
promoteROSproductioninskeletalmuscleﬁbres(Powers
& Jackson, 2008).
During the 1980s and 1990s it was widely assumed that
muscular activity- or inactivity-induced ROS production
was cytotoxic to skeletal muscle ﬁbres. However, growing
evidence indicates that increased ROS production plays
an important role in the regulation of signalling pathways
that are required to promote skeletal muscle adaptation
in response to both exercise and muscle inactivity. The
discovery that ROS play an important role in skeletal
muscleadaptationtoalteredactivitypatternsisanexciting
new area of research and is the focus of this review.
Speciﬁcally,thisreportprovidesanoverviewofourcurrent
knowledgeaboutseveralpotentialsignallingpathwaysthat
link ROS to the remodelling that occurs in skeletal muscle
during both exercise training and during prolonged
periods of muscle disuse. The ﬁrst segment of this review
identiﬁes the potential sites of ROS production in skeletal
muscle. This is followed by several important examples
of how ROS interact with cellular signalling pathways
that regulate gene expression and, therefore, contribute
to skeletal muscle remodelling. We then discuss ﬁndings
which support the notion that cellular ROS production
plays an essential role in skeletal muscle adaptation to
bothexerciseanddisuse.Weconcludewithadiscussionof
the voids in our knowledge about redox control of muscle
adaptation in the hope of stimulating future research in
this ﬁeld.
Sources of ROS production in skeletal muscle
The primary radicals generated in cells are superoxide
and nitric oxide, and both can activate a variety of
cell signalling pathways (Halliwell & Gutteridge, 2007).
Superoxide is generated by the addition of one electron
to ground-state oxygen; this can occur via one-electron
transfer in the mitochondrion and by several enzymatic
systems located within cells. Speciﬁcally, superoxide
production can occur at multiple locations within the
muscle ﬁbre, including the mitochondrion, sarcoplasmic
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reticulum,transversetubules,sarcolemmaandthecytosol
(Fig. 1). The main sites of superoxide production
in the mitochondria are complexesI and III of the
electron transport chain (Barja, 1999). Furthermore,
recentﬁndingsindicatethatcomparedwithmitochondria
from slow typeI muscle ﬁbres, mitochondria from fast
typeII muscle ﬁbres possess unique properties that
promote higher levels of ROS production (Anderson
& Neufer, 2006). The mechanism(s) to explain these
differences remains unknown.
The NADPH oxidases located within the sarcoplasmic
reticulum, transverse tubules and the sarcolemma also
produce superoxide in skeletal muscle ﬁbres (Powers &
Jackson, 2008). For example, it has been reported that the
transverse tubule NADPH oxidase produces superoxide
which stimulates calcium release from the triads (Hidalgo
et al. 2006). Nonetheless, limited information currently
exists about the regulation of these systems in muscle
during exercise or during prolonged disuse.
Evidence also indicates that xanthine oxidase produces
superoxide in the cytosol of contracting rat skeletal
muscles(Gomez-Cabreraetal.2005).However,compared
with rats, human skeletal muscles contain lower levels of
xanthine oxidase, and there is continuing debate about
whether xanthine oxidase plays an important role in
superoxide production in human skeletal muscle (Linder
et al. 1999; G´ omez-Cabrera et al. 2003).
The dismutation of superoxide in cells produces
hydrogen peroxide (H2O2), and this process can occur
spontaneously or by action of the superoxide dismutases
(Halliwell & Gutteridge, 2007). Hydrogen peroxide is a
non-radicalandaweakoxidantwitharelativelylonghalf-
life; this long half-life permits diffusion within cells and
across cell membranes (Halliwell & Gutteridge, 2007).
Furthermore, H2O2 reacts with many different cellular
moleculesandcanactivateavarietyofsignallingpathways.
Collectively, these properties make H2O2 an important
ROS signalling molecule in cells (Veal et al. 2007).
Figure 1. An illustration of the potential sources of reactive
oxygen species (ROS) production in skeletal muscle
Note that superoxide anions (O2
•−) can be produced at several sites
within muscle ﬁbres, including NADPH oxidase, xanthine oxidase and
mitochondria. Abbreviations: NO•,n i t r i co x i d e ;O 2
•−, superoxide
anion; and ONOO−, peroxynitrate.
Nitric oxide is synthesized from the amino acid
L-arginine by three different isoforms of nitric oxide
synthase (NOS1, NOS2 and NOS3). Furthermore, a
fourth mitochondrial nitric oxide synthase may also exist
(Ghafourifar&Cadenas,2005).Normally,skeletalmuscle
expresses two of these isoforms (i.e. NOS1 and NOS3;
Moylan & Reid, 2007). However, NOS2 can also be
expressed in skeletal muscle during inﬂammatory states
(Moylan&Reid,2007).Nitricoxideisknowntohavemany
signalling functions and can readily react with superoxide
to form the strong oxidizing agent, peroxynitrite, leading
to the depletion of thiol groups in cells (Moylan &
Reid, 2007). This modiﬁcation of cellular thiol groups
could alter redox signalling and may play an important
role in numerous cell signalling pathways (Jones, 2006).
Peroxynitrite formation also reduces the bioavailability
of both superoxide and nitric oxide, which could also
inﬂuence cell signalling events (Halliwell & Gutteridge,
2007; Powers & Jackson, 2008).
Examples of redox-mediated signalling pathways
ManystudiesindicatethatROSareimportantmessengers
in signalling pathways leading to cellular adaptation
(Allen & Tresini, 2000). Recent evidence reveals that
ROS signalling contributes to muscle ﬁbre adaptation
in response to both increased contractile activity (i.e.
muscularexercise)andprolongedperiodsofmuscledisuse
(e.g. immobilization). This seemingly contradictory
signalling function of ROS is probably due to differences
in both the magnitude and the temporal pattern of
ROS generation. For example, a moderate increase in
skeletal muscle ROS production during a short time
period (e.g. minutes) can activate signalling pathways
leadingtocellularadaptationandprotectionagainstfuture
stresses. In contrast, high levels of ROS production over
long time periods (e.g. hours) may result in chronic
activation of signalling pathways that promote proteolysis
and potentially cell death (Ji et al. 2006).
How do changes in the redox status of muscle ﬁbres
regulate signalling pathways and gene expression? At
present,acompleteanswertothisquestionisnotavailable.
Nonetheless, it is clear that redox signalling can inﬂuence
numerous transcriptional activators leading to altered
gene expression and changes in muscle phenotype. In
general, a major mechanism by which redox signalling
controls gene expression is via the phosphorylation status
of transcriptional activating factors. Indeed, ROS play
a key role in controlling the activities of many kinases
and phosphatases (Chiarugi & Cirri, 2003; Torres &
Forman, 2003). Moreover, ROS are known to activate
the transcriptional factor nuclear factor-κB( N F - κB;
Kandarian & Jackman, 2006). A brief discussion of these
topics follows.
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Regulation of cellular kinases by ROS
Many families of kinases exist in cells, and a detailed
discussion of kinases exceeds the scope of this review.
Nonetheless, as an illustration of ROS signalling in
muscle ﬁbres, we will highlight the mitogen-activated
protein kinase (MAPK) family as one of the important
links between cellular ROS levels and skeletal muscle
adaptation. It is well established that MAPKs play
a key role in cell signalling, because the control of
numerous cellular signalling pathways is achieved via
activation or deactivation of regulatory proteins through
phosphorylation (Cuschieri & Maier, 2005). Indeed, the
highly conserved MAPK family is one of the major kinase
families that regulate the conversion of cell signals into
cellular responses. These protein kinases contribute to the
regulation of life-and-death decisions made in response
to various stress signals (e.g. ROS; Matsuzawa & Ichijo,
2005).
All eurkaryotic cells possess multiple MAPK pathways.
The three best-characterized MAPK subfamilies are c-Jun
N-terminal kinase (JNK), p38 MAPK and extracellular
signal-regulated kinase (ERK; Chen et al. 2001). All
three of these MAPK pathways are structurally similar,
but functionally distinct. Importantly, ERK, JNK and
p38 MAPK have all been shown to be activated by
oxidative stress and could potentially participate in
pathways inﬂuencing muscle protein breakdown or loss
of nuclei via myonuclear apoptosis (Torres & Forman,
2003; Li et al. 2005). The classic MAPK activation cascade
consists of three sequential intracellular protein kinase
activation steps leading to the activation of numerous
proteinkinases,nuclearproteinsandtranscriptionfactors,
resulting in downstream signal transduction (Chen et al.
2001; Cuschieri& Maier,2005; Fig. 2). A briefoverview of
the functions of ERK, p38 and JNK follows.
Extracellular signal-regulated kinase 1/2. The ﬁrst-
identiﬁed and best-studied MAPK cascade is the ERK
pathway(Cuschieri&Maier,2005;Meloche&Pouyssegur,
2007). Extracellular signal-regulated kinase is composed
of two isoforms, ERK1 and ERK2, collectively referred
to as ERK1/2 (Chen et al. 2001; Cuschieri & Maier,
2005). Extracellular signal-regulated kinase1/2 can be
activated by a number of mitogens, including epidermal
growth factor, platelet-derived growth factor and ROS
(Cuschieri & Maier, 2005). The activation of ERK1/2
by oxidative stress is consistent with the hypothesis that
low and adequate levels of ROS are mitogenic (Chen
et al. 2001; Qi & Elion, 2005). Activation of ERK1/2
regulatesthetranscriptionalactivityofactivatorprotein-1
(AP-1), c-Myc and the cell survival protein B-cell
lymphoma-2 (Bcl-2; Qi & Elion, 2005). Although it is
an oversimpliﬁcation, in general, activation of ERK1/2
promotes cellular adaptations that lead to survival (Chen
et al. 2001).
p38 MAPK. p38 is an important MAPK family member
that is activated in response to various physiological
stresses,suchasosmoticstress,endotoxinsandROS(Chen
etal.2001).Animportantlinkbetweenoxidativestressand
p38 activation occurs via apoptosis-stimulating kinase1
(ASK1;Matsuzawa&Ichijo,2005).Apoptosis-stimulating
kinase1isaubiquitouslyexpressedmemberoftheMAPK
familythatactivatesbothp38andJNKbyphosphorylating
and activating these MAPK kinases. Five isoforms of p38
have been identiﬁed: p38α,p 3 8 β,p 3 8 β2, p38γ and p38δ,
and expression of these isoforms varies between tissues.
Forexample,p38αishighlyexpressedinbonemorrowand
leukocytes,p38βisexpressedinheartandbrain,andp38γ
is predominantly expressed in skeletal muscle (Cuschieri
& Maier, 2005).
Among the phosphorylation targets of p38 are several
important transcription factors, including p53, NF-κB
and ATF2. Of particular importance to apoptosis is the
fact that activation of the tumour suppressor protein
p53 results in the expression of the pro-apoptosis
protein, Bax. Increased expression of Bax in cells can
promote caspase-3 activation via a mitochondrion-
mediated pathway (Primeau et al. 2002). Moreover, p38
signalling can promote the expression of the muscle-
speciﬁc E3 ligase atrogin1 in myotubes (Li et al.
Figure 2. Illustration of the interaction of kinases and
phosphatases in the regulation of transcription factors and
subsequent protein synthesis in skeletal muscle
C   2009 The Authors. Journal compilation C   2010 The Physiological Society4 S. K. Powers and others Exp Physiol 95.1 pp 1–9
2005). Collectively, these ﬁndings suggest a potential role
for ROS-induced activation of p38 in muscle atrophy.
Nonetheless, deﬁnitive evidence linking p38 as a causative
factor in disuse muscle atrophy does not currently exist.
c-Jun N-terminal kinase. c-Jun N-terminal kinase (also
knownasstress-inducedkinase)hasthreeisoforms(JNK1,
JNK2andJNK3)thatareencodedbythreedifferentgenes.
While JNK1 and JNK2 are ubiquitously expressed, JNK3
is only expressed in brain, heart and testis (Cuschieri &
Maier, 2005). c-Jun N-terminal kinase can be activated in
response to many of the same stimuli that activate p38,
such as osmotic stress, endotoxins and ROS. Moreover,
similar to p38, oxidative stress-induced activation of JNK
occurs via the ASK1 pathway (Shen & Liu, 2006).
The speciﬁc molecular targets of JNK include the
transcriptional factors AP-1, p53 and c-Myc and many
other non-transcriptional factors, such as Bcl-2 family
members. In this regard, there is growing evidence
that JNK plays an important role in oxidative stress-
mediated apoptosis. Indeed, because ROS themselves are
not able to activate caspases, ROS-mediated apoptosis
requires another death-signalling pathway, such as JNK
(Matsuzawa & Ichijo, 2005; Shen & Liu, 2006).
Regulation of cellular phosphatases by ROS
Changes in the phosphorylation status of signalling
molecules play an important role in the control of cellular
adaptation.Inthisregard,itisimportanttoappreciatethat
the phosphorylation status of regulatory proteins and/or
transcriptional activators is regulated not only by kinase
activitybutalsobychangesinphosphataseactivity(Fig.2).
Ingeneral,phosphatasesaredividedintotwomajorclasses
(i.e. serine/threonine phosphatases and phosphotyrosine
phosphatases), both of which are known to be redox
sensitive in many different cell types, including skeletal
muscle. Similar to our discussion of kinases, a detailed
discussionofphosphatasesexceedsthegoalsofthisreview,
but examples of important redox-sensitive phosphatases
in skeletal muscle are provided in the subsections that
follow.
Serine/threonine phosphatases, named for the amino
acid residues from which they remove phosphate
groups, contain metal ions that are susceptible
to oxidation. An important example of a redox-
sensitive serine/threonine phosphatase that is crucial to
skeletal muscle adaptation is calcineurin. The calcium–
calmodulin-dependent calcineurin is involved in both
muscle hypertrophy and ﬁbre phenotype transformation,
probably via the transcription factor nuclear factor
of activated T-cells (NFAT; Dunn et al. 1999; Michel
et al. 2004; Bassel-Duby & Olson, 2006). Calcineurin
dephosphorylates NFAT, allowing NFAT to translocate
to the nucleus and increase expression of genes that
contribute to muscle hypertrophy (Calabria et al. 2009).
Importantly,oxidationcaninhibitcalcineurinbyblocking
itsbindingdomainforcalmodulinandthuspreventingits
activation (Carruthers & Stemmer, 2008). Also, inhibitors
of serine/threonine phosphatases have been shown to
activate NF-κB, another redox-sensitive transcription
factor that will be discussed in the next subsection (Sen
et al. 1996).
Similar to serine/threonine phosphatases, the
phosphotyrosinephosphatases(PTPs)arealsosusceptible
to oxidation-induced inactivation. The PTPs contain
a conserved cysteine residue in their active site, and
oxidation of this cysteine inactivates the enzyme (Tonks,
2005). A subclass of PTPs, called dual-speciﬁcity
phosphatases (DUSPs), can remove phosphates from
both tyrosine and serine/threonine residues. The
DUSPs contain two cysteines in their active sites,
leading to inactivation of the enzyme during oxidizing
conditions. Of particular importance in skeletal muscle
is phosphatidylinositol 3-phosphatase (PTEN). Active
PTEN dephosphorylates phosphatidylinositol (3,4,5)-
triphosphate, thereby blocking many cell signalling
pathways, including Akt activation (Maehama & Dixon,
1998). Exogeneous hydrogen peroxide has been shown to
oxidize PTEN, inactivating the enzyme and promoting
Akt activation (Leslie et al. 2003). Furthermore, the
MAPK family is also regulated by a group of DUSPs,
which inactivate MAPKs by cleaving their phosphate
groups (Camps et al. 2000).
Redox balance and NF-κB activation
Another important link between ROS and skeletal muscle
remodelling involves the redox regulation of the NF-
κB family of transcriptional activators. Indeed, evidence
indicates that the NF-κB pathway is required for skeletal
muscleadaptationtobothexerciseandinactivity-induced
atrophy (Kandarian & Stevenson, 2002; Jackman &
Kandarian, 2004; Kandarian & Jackman, 2006). In this
regard, NF-κB regulates the expression of over 150 genes,
and emerging research continues to identify the speciﬁc
NF-κB targets required for skeletal muscle remodelling
(Kramer & Goodyear, 2007).
Nuclear factor-κB comprises a family of ﬁve
transcriptionfactors(p65,RelB,c-Rel,p52andp50).Two
of these proteins must dimerize to facilitate binding of
NF-κB to DNA and, when activated, NF-κBc a np r o m o t e
a wide range of cellular outcomes depending upon the
cell type (Jackman & Kandarian, 2004). All ﬁve of the
NF-κB family members are expressed in skeletal muscle,
butrecentevidencesuggeststhatthep50–p65heterodimer
isresponsibleforthe majorityof NF-κBactivity inmuscle
(Jackman & Kandarian, 2004).
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In unstressed cells, the nuclear localization sequence of
NF-κB is bound to inhibitory IκB proteins in the cytosol,
which prevents dimerization of p50 to p65 and therefore
prevents movement into the nucleus. However, increased
cytosolic ROS levels can activate IκB-α kinase (IKK),
resulting in the phosphorylation of IκB proteins, which
initiates ubiquitination and subsequent IκBd e g r a d a t i o n
via the proteasome (Kabe et al. 2005). Degradation of IκB
removes the inhibition and liberates NF-κBc o m p l e x e s
so that dimerization and nuclear translocation can occur
(Kabe et al. 2005).
Although ROS can promote NF-κBa c t i v a t i o na n d
subsequent gene expression, the DNA binding activity
of oxidized NF-κB is diminished, suggesting that ROS
may also inhibit NF-κB transcriptional activity (Kabe
et al. 2005). Therefore, while NF-κB was once considered
to be a prototypic redox-sensitive transcription factor,
t h ef a c tt h a tR O Sc a nb o t hp r o m o t ea n di n h i b i tN F - κB
transcriptional activation has led to considerable debate
regarding the redox control of NF-κB signalling (Pantano
et al. 2006). Additional work will be required to unravel
the uncertainties about the redox regulation of NF-κBi n
physiologically relevant settings in skeletal muscle.
Reactive oxygen species and skeletal muscle
adaptation to exercise
Physical exercise promotes signalling responses in skeletal
muscle leading to alterations in protein synthesis and
musclephenotype.Forexample,asfewasﬁveconsecutive
days of endurance exercise (i.e. 60minday−1 at 60% of
maximal oxygen uptake) promotes an increase in both
mitochondrial enzymes and antioxidants in the active
skeletal muscles (Vincent et al. 2000). The fact that ROS
are generated in contracting muscles and many signalling
pathways are redox sensitive has raised the question of
whether contraction-induced ROS production plays an
essential role in skeletal muscle adaptation to aerobic
exercise training. The short answer to this question is yes,
and evidence to support this position follows.
Davies and colleagues provided the ﬁrst suggestion
that ROS production is a stimulus for skeletal muscle
adaptation to exercise training (Davies et al. 1982). Since
this initial proposal, many studies have supported this
concept. For example, abundant in vitro studies have
demonstrated that exposure of cultured myotubes to
oxidants(e.g.hydrogenperoxide)promotestheexpression
of numerous genes (Li et al. 2003; McArdle et al. 2004;
Hansenetal.2007;Irrcheretal.2009;McClungetal.2009).
Speciﬁcally, hydrogen peroxide exposure has been shown
to augment the expression of key antioxidant enzymes
in myotubes (Franco et al. 1999). Moreover, a recent
study reveals that exposure of myotubes to exogenous
hydrogen peroxide increases peroxisome proliferator-
activated receptor-γ coactivator-1 protein-α (PGC-1α)
promoter activity and mRNA expression (Irrcher et al.
2009). Importantly, both effects were blocked when the
antioxidant N-acetylcysteine was added to the culture
medium.IthasalsobeenreportedthatROSproductionis
arequirementforcontraction-inducedgeneexpressionof
PGC-1α in primary rat muscle cells (Silveira et al. 2006).
Collectively, these in vitro experiments demonstrate that
ROS are capable of altering gene expression in cultured
muscle cells.
Similar to the aforementioned cell culture studies,
numerous reports support the concept that exercise-
induced ROS production alters muscle gene expression
andcontributestoexercise-inducedadaptationsofskeletal
muscle in vivo. A common approach in many of
these studies is to abolish the signalling effects of
exercise-induced ROS production in skeletal muscle
by treating animals or humans with antioxidants. For
example, two independent reports have demonstrated
that exercise-induced expression of heat shock protein72
in rat skeletal and cardiac muscle is suppressed by
antioxidant supplementation (Hamilton et al. 2003;
Jackson et al. 2004). Also, two independent studies
haverecentlyconcludedthatantioxidantsupplementation
can retard important training adaptations in human
skeletal muscle (Gomez-Cabrera et al. 2008; Ristow
et al. 2009). Speciﬁcally, Gomez-Cabrera et al. (2008)
reported that oral administration of vitaminC in humans
prevented exercise-induced expression of PGC-1α and
mitochondrialbiogenesisinskeletalmuscle.Furthermore,
vitaminC treatment also prevented exercise-induced
expression of several antioxidant enzymes in muscle
(Gomez-Cabrera et al. 2008). Similar results in humans
havebeenreportedbyRistowetal.(2009).Together,these
ﬁndings support the conclusion that ROS production
plays an essential role in exercise-induced skeletal muscle
adaptation.
Redox signalling and skeletal muscle remodelling
during prolonged disuse
As discussed throughout this report, abundant evidence
indicates that ROS serve as second messengers in cellular
signal transduction pathways that regulate both normal
physiological signalling and pathological signalling. This
seemingly contradictory signalling function of ROS is
probably linked to the level of ROS and the duration
of the redox disturbances in the cell. For example, acute
increases in ROS promote cell adaptation and survival,
whereaschronicallyelevatedlevelsofROSproductioncan
modulate signalling pathways that lead to proteolysis and
cell death (Powers et al. 2005, 2007).
It is now well accepted that oxidative stress occurs in
skeletal muscle during prolonged disuse and that redox
disturbances regulate signalling pathways that contribute
tomuscleremodelling(e.g.atrophyandlossofmyonuclei
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via myonuclear apoptosis) during these conditions. The
ﬁrst evidence that oxidants play a signalling role in
the regulation of disuse muscle atrophy was provided
by Kondo et al. (1991). This pioneering work revealed
that immobilization of skeletal muscles is associated with
increased radical production, resulting in oxidative injury
in inactive muscle ﬁbres. Importantly, this work also
demonstratedthatdisusemuscleatrophycouldbedelayed
by exogenous antioxidants. These early observations have
subsequentlybeenconﬁrmedbyothers(Appelletal.1997;
Betters et al. 2004; McClung et al. 2007b).
The cellular sites of ROS production in skeletal muscle
during prolonged inactivity remain a topic of debate.
Nonetheless, xanthine oxidase has been shown to be a
potential source of oxidant production in rat skeletal
muscle during prolonged periods of inactivity (Whidden
et al. 2009). Moreover, recent evidence indicates that
mitochondria may also be an important source of ROS
production in skeletal muscle during inactivity (Kavazis
et al. 2009). In contrast, NOS-mediated production
Figure 3. Reactive oxygen species are predicted to activate several proteolytic pathways, including
calpains, caspase-3 and the proteasome system in skeletal muscle
of nitric oxide does not appear to play a role in
disuse-induced oxidative stress in skeletal muscle (Van
Gammeren et al. 2007).
How does inactivity-induced oxidative stress in skeletal
muscle contribute to muscle atrophy? At present, a
complete answer to this question is not available.
Nonetheless, it appears that oxidative stress could
contribute to disuse muscle atrophy by activation of one
or more proteolytic pathways (e.g. calpain, caspase-3
activation and/or the ubiquitin–proteasome pathway;
Fig.3). A brief discussion of these possibilities follows.
Calpains. Calpains are a family of cellular proteases that
areactivatedbyincreasesincytosoliclevelsoffreecalcium
(Golletal.2003).Itisestablishedthatcalpainsareactivated
during disuse muscle atrophy and that calpain activation
may be an initial and required step for disuse muscle
atrophy to occur (Goll et al. 2003; Maes et al. 2007).
Although the mechanism responsible for this inactivity-
mediated calcium overload is unknown, it is possible that
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intracellular production of ROS could play a key role
in disturbances in calcium homeostasis (Kandarian &
Stevenson, 2002). There are at least three mechanisms
by which an increase in cellular ROS production can
promote increased cytosolic levels of free calcium. First,
in cell-free systems, oxidation of the ryanodine-sensitive
calciumreleasechannelresultsincalciumreleasefromthe
sarcoplasmicreticulum(Powers&Jackson,2008).Second,
high levels of ROS can inhibit sarcoplasmic Ca2+-ATPase
(i.e. SERCA) activity and retard calcium reuptake into the
sarcoplasmic reticulum (Powers & Jackson, 2008). A third
potential biochemical mechanism to link oxidative stress
with calcium overload is that ROS-mediated formation of
reactive aldehydes (i.e. 4-hydroxy-2,3-trans-nonenal) can
inhibit plasma membrane Ca2+-ATPase activity (Siems
et al. 2003). Hence, an oxidative stress-induced decrease
in membrane Ca2+-ATPase activity would impede Ca2+
removal from the cell and promote intracellular Ca2+
accumulation. Collectively, these mechanisms may act
independently or interact to promote oxidative stress-
induced calcium overload in cells.
Caspase-3. Emerging evidence suggests that caspase-3
may play an important role in disuse muscle atrophy
(McClung et al. 2007a). Indeed, caspase-3 activation is
capable of promoting degradation of intact actin–myosin
complexes, and inhibition of caspase-3 activity has been
shown to retard inactivity-induced atrophy and loss of
myonuclei due to myonuclear apoptosis (Du et al. 2004;
McClung et al. 2007a). Although the control of caspase-3
activity is complex and involves several interconnected
pathways, it is feasible that inactivity-associated ROS
production in skeletal muscle contributes to caspase-3
activation. Indeed, increased cellular levels of ROS have
been reported to activate caspase-3 in a wide variety of
cell types, including skeletal muscle (Primeau et al. 2002).
In this regard, oxidative stress has been postulated to
contribute to caspase-3 activation via both mitochondrial
and endoplasmic reticulum signalling pathways (Primeau
et al. 2002). As discussed previously, in the section ‘p38
MAPK’, ROS-induced activation of p38 and/or JNK may
playimportantrolesintheredoxsignallingcascadeleading
to capase-3 activation.
Ubiquitin–proteasome system. Finally, several lines of
evidence indicate that ROS signalling is involved in
the regulation of the ubiquitin–proteasome system. For
example, oxidative stress has been shown to stimulate
ubiquitin conjugation to muscle proteins through the
transcriptional regulation of the enzymes (i.e. E2 and E3
proteins) that conjugate ubiquitin to muscle proteins to
promote proteolysis (Li et al. 2003). In theory, increased
expression of these E2 and E3 proteins in skeletal
muscle would lead to accelerated proteolysis via the 26S
proteasome. Furthermore, evidence indicates that the 20S
(core) proteasome can degrade oxidized proteins without
ubiquitination (Grune et al. 2003). Therefore, it is likely
that oxidant stress can accelerate muscle protein break-
down via both the 20S and the 26S proteasome.
Conclusions and unanswered questions
Paradoxically, both contractile activity and prolonged
periods of muscle disuse promote increased ROS
production in skeletal muscle ﬁbres. Importantly, ROS
serve as signalling molecules in each of these conditions
to inﬂuence biochemical pathways and gene expression.
Speciﬁcally, many signalling molecules are manipulated
by ROS, including redox-sensitive kinases, phosphatases
and the transcription factor NF-κB. These redox-sensitive
molecules act as downstream effectors of ROS and
serve as critical signalling events leading to skeletal
muscle remodelling in response to increased contractile
activity (i.e. physical exercise) or during disuse (e.g.
immobilization).
Although progress has been made in understanding
the role of ROS as signalling molecules in muscle ﬁbres,
manyunansweredquestionsremain.Afundamentalquery
of great importance is ‘how does ROS production in
skeletalmuscleﬁbrespromoteanabolicresponsesinsome
conditions (e.g. exercise training), whereas in other states
(e.g. disuse), cellular ROS production promotes catabolic
signalling?’ Several potential explanations exist for this
dichotomy, including differences in the oxidant species
produced, divergence in the temporal pattern of ROS
production (i.e. acute versus chronic ROS production),
disparity in the levels of ROS produced and/or differences
in the cellular locations of ROS production. Systematic
and well-controlled studies are needed to address these
important issues.
An on-going limitation in redox biology investigations
istheproblemofquantifyingthelevelsofdifferentROSin
livecells.Indeed,thisrestrictionhasdelayedadvancements
in this ﬁeld for several years. The creation of sensitive and
reliable technique(s) to quantify the levels of ROS in cells
or tissues would greatly accelerate progress in oxidative
stress research.
Note that much of the evidence linking ROS signalling
to muscle adaptation is based on transcriptional changes
(i.e. increased or decreased mRNA) in the cell. Future
studiesshouldalsoinvestigatetherolethatROSsignalling
plays in the rates of translation and in post-translational
modiﬁcations of proteins.
Hopefully, the questions outlined in this review will
stimulate muscle biologists to pursue research in the
emerging ﬁeld of redox signalling. Future technical
advances in cell signalling will provide powerful tools for
useinredoxstudiesandwillsupplynewopportunitiesfor
scientists to address the important questions outlined in
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this report. Clearly, the ﬁeld of redox signalling in skeletal
muscle is at an exciting stage.
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